Uses of Immunotherapy in Epithelial Ovarian Cancer
The
DOI:
https://doi.org/10.58445/rars.1155Keywords:
Immunotherapy, Epithelial Ovarian Cancer, WomenAbstract
Ovarian cancer is something many women throughout the world struggle with. Among the different types of ovarian cancer, epithelial ovarian cancer (EOC) constitutes the majority. EOC specifically has a high recurrence rate hence many patients will often undergo an oophorectomy which is surgical removal of the ovaries. Immunotherapies in EOC can make a significant impact on women who wish to not undergo a major surgery or, especially for younger women, want to preserve their fertility, due to it's potential for long lasting results. In this review paper we will discuss immunotherapy options for patients with epithelial ovarian cancer and ongoing trials for developing immunotherapies for EOC.
References
Capellero, S., Erriquez, J., Melano, C., Mesiano, G., Genta, S., Pisacane, A., Mittica, G., Ghisoni, E., Olivero, M., Di Renzo, M. F., Aglietta, M., Sangiolo, D., & Valabrega, G. (2020). Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer. Scientific reports, 10(1), 6478. https://doi.org/10.1038/s41598-020-63634-z
Gubbles, J., & Claussen, N., & Kapur, A. K., & Connor, J. P., & Patanker, M. P. The detection, treatment, and biology of epithelial ovarian cancer. The Journal of Ovarian Research.
Hartnett, E., Knight , J., Radolec, M., Bukanovich, R., Edwards, R., & Vlad, A. (2020). Immunotherapy Advances for Epithelial Ovarian Cancer. MDPI.
NCT04918186
NCT05397093
Downloads
Posted
Categories
License
Copyright (c) 2024 Geethika Menon
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.